| Remedium which engages in trading in API intermediates (KSMs & CRMs) and various other raw materials used in API trading. viz., Amino isophthalic Acid, Tellurium(IV) Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, Trimethyl Sulfoxonium Iodide(TMSI), has further strengthened its performance and presence in the pharma & healthcare domain. Remedium has made a paradigm shift by entering into the trading of intermediates and APIs and be reckoned as a leading contract trader and as a brand owner of advanced intermediates & APIs Remedium Lifecare Ltd. (formerly known as Roxy Exports Limited) is a BSE listed company. 2020 -Company name has changed to Remedium Lifecare Ltd. from Roxy Exports Ltd.. 2023 -The Company has issued Bonus Shares in the Ratio of 9:5. -Company has splits its face value from Rs. 10/- to Rs. 5/-. 2024 -The Company has issued Bonus Shares in the Ratio of 3:1. 2025 -The company issued rights shares of Rs. 1 in the ratio of 61:50 at par. - Remlife Global Partners with JiyaYu to Replace Animal-Origin Inputs in APIs. 2026 -Company name has changed to Supha Pharmachem Ltd. from Remedium Lifecare Ltd. |
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article